Publications by authors named "S A Jayawardene"
Catalytic reduction of 4-nitrophenol using CuO@NaTi(PO)⋅HO.
J Environ Sci Health A Tox Hazard Subst Environ Eng
January 2022
This article presents the synthesis, property characterization and catalytic application of CuO-supported disodium titanium phosphate, (CuO@NaTi(PO)⋅HO) for the reduction of industrial pollutant 4-nitrophenol (4-NP). A simple hydrothermal route was developed to synthesize CuO@NaTi(PO)⋅HO catalyst (CuO@NaTiP) from beach sand ilmenite. The prepared CuO@NaTiP was characterized using X-ray diffraction, scanning electron microscopy, energy dispersive X-ray analysis, X-ray photoelectron spectroscopy, and nitrogen adsorption-desorption isotherms.
View Article and Find Full Text PDFBackground: Acute kidney injury (AKI) is common among patients hospitalised with COVID-19 and associated with worse prognosis. The aim of this study was to investigate the epidemiology, risk factors and outcomes of AKI in patients with COVID-19 in a large UK tertiary centre.
Methods: We analysed data of consecutive adults admitted with a laboratory-confirmed diagnosis of COVID-19 across two sites of a hospital in London, UK, from 1st January to 13th May 2020.
Article Synopsis
- The COVID-19 pandemic saw increased rates of acute kidney injury (AKI) in critically ill patients, raising the need for renal replacement therapy (RRT), particularly challenging due to the high demand in ICUs.
- The study evaluated the safety and efficacy of peritoneal dialysis (PD) as an alternative to continuous renal replacement therapy (CRRT) by analyzing catheter insertion and patient outcomes.
- Results showed successful catheter insertions with no reported complications, stable patient conditions post-insertion, and a median 94.6% RRT coverage through PD, indicating it as a viable option for managing AKI in ventilated COVID-19 patients.
Background: Acute kidney injury (AKI) in pregnancy (Pr-AKI) is associated with substantial maternal morbidity and mortality. E-alerts are routinely used for detection of AKI in non-pregnant patients but their role in maternity care has not been explored.
Methods: All pregnant or postpartum women with AKI e-alerts for AKI Stages 1-3 (Kidney Disease Improving Global Outcomes (KDIGO) criteria) were identified at a tertiary centre >2 years.